1065 related articles for article (PubMed ID: 28886081)
1. Orexin A affects HepG2 human hepatocellular carcinoma cells glucose metabolism via HIF-1α-dependent and -independent mechanism.
Wan X; Liu Y; Zhao Y; Sun X; Fan D; Guo L
PLoS One; 2017; 12(9):e0184213. PubMed ID: 28886081
[TBL] [Abstract][Full Text] [Related]
2. Effects of orexin A on glucose metabolism in human hepatocellular carcinoma in vitro via PI3K/Akt/mTOR-dependent and -independent mechanism.
Liu Y; Zhao Y; Guo L
Mol Cell Endocrinol; 2016 Jan; 420():208-16. PubMed ID: 26549689
[TBL] [Abstract][Full Text] [Related]
3. Sirolimus increases the anti-cancer effect of Huai Er by regulating hypoxia inducible factor-1α-mediated glycolysis in hepatocellular carcinoma.
Zhou L; Zhao Y; Pan LC; Wang J; Shi XJ; Du GS; He Q
World J Gastroenterol; 2022 Aug; 28(32):4600-4619. PubMed ID: 36157928
[TBL] [Abstract][Full Text] [Related]
4. Oroxylin A regulates glucose metabolism in response to hypoxic stress with the involvement of Hypoxia-inducible factor-1 in human hepatoma HepG2 cells.
Dai Q; Yin Q; Wei L; Zhou Y; Qiao C; Guo Y; Wang X; Ma S; Lu N
Mol Carcinog; 2016 Aug; 55(8):1275-89. PubMed ID: 26259145
[TBL] [Abstract][Full Text] [Related]
5. Knockdown of KLF5 suppresses hypoxia-induced resistance to cisplatin in NSCLC cells by regulating HIF-1α-dependent glycolysis through inactivation of the PI3K/Akt/mTOR pathway.
Gong T; Cui L; Wang H; Wang H; Han N
J Transl Med; 2018 Jun; 16(1):164. PubMed ID: 29898734
[TBL] [Abstract][Full Text] [Related]
6. Orexin A protects cells from apoptosis by regulating FoxO1 and mTORC1 through the OX1R/PI3K/AKT signaling pathway in hepatocytes.
Ju SJ; Zhao Y; Chang X; Guo L
Int J Mol Med; 2014 Jul; 34(1):153-9. PubMed ID: 24807827
[TBL] [Abstract][Full Text] [Related]
7. Wortmannin influences hypoxia-inducible factor-1 alpha expression and glycolysis in esophageal carcinoma cells.
Zeng L; Zhou HY; Tang NN; Zhang WF; He GJ; Hao B; Feng YD; Zhu H
World J Gastroenterol; 2016 May; 22(20):4868-80. PubMed ID: 27239113
[TBL] [Abstract][Full Text] [Related]
8. Hypoxia-independent overexpression of hypoxia-inducible factor 1alpha as an early change in mouse hepatocarcinogenesis.
Tanaka H; Yamamoto M; Hashimoto N; Miyakoshi M; Tamakawa S; Yoshie M; Tokusashi Y; Yokoyama K; Yaginuma Y; Ogawa K
Cancer Res; 2006 Dec; 66(23):11263-70. PubMed ID: 17145871
[TBL] [Abstract][Full Text] [Related]
9. Bufalin suppresses hepatocellular carcinoma invasion and metastasis by targeting HIF-1α via the PI3K/AKT/mTOR pathway.
Wang H; Zhang C; Xu L; Zang K; Ning Z; Jiang F; Chi H; Zhu X; Meng Z
Oncotarget; 2016 Apr; 7(15):20193-208. PubMed ID: 26958938
[TBL] [Abstract][Full Text] [Related]
10.
Canales J; Valenzuela M; Bravo J; Cerda-Opazo P; Jorquera C; Toledo H; Bravo D; Quest AF
Front Cell Infect Microbiol; 2017; 7():92. PubMed ID: 28401064
[No Abstract] [Full Text] [Related]
11. Effect of Glut-1 and HIF-1α double knockout by CRISPR/CAS9 on radiosensitivity in laryngeal carcinoma via the PI3K/Akt/mTOR pathway.
Bao YY; Zhong JT; Shen LF; Dai LB; Zhou SH; Fan J; Yao HT; Lu ZJ
J Cell Mol Med; 2022 May; 26(10):2881-2894. PubMed ID: 35415942
[TBL] [Abstract][Full Text] [Related]
12. Basic fibroblast growth factor regulates glucose metabolism through glucose transporter 1 induced by hypoxia-inducible factor-1α in adipocytes.
Kihira Y; Yamano N; Izawa-Ishizawa Y; Ishizawa K; Ikeda Y; Tsuchiya K; Tamaki T; Tomita S
Int J Biochem Cell Biol; 2011 Nov; 43(11):1602-11. PubMed ID: 21810481
[TBL] [Abstract][Full Text] [Related]
13. Combining combretastatin A4 phosphate with ginsenoside Rd synergistically inhibited hepatocellular carcinoma by reducing HIF-1α via PI3K/AKT/mTOR signalling pathway.
Yang X; Gao M; Miao M; Jiang C; Zhang D; Yin Z; Ni Y; Chen J; Zhang J
J Pharm Pharmacol; 2021 Mar; 73(2):263-271. PubMed ID: 33793802
[TBL] [Abstract][Full Text] [Related]
14. Resveratrol suppresses cancer cell glucose uptake by targeting reactive oxygen species-mediated hypoxia-inducible factor-1α activation.
Jung KH; Lee JH; Thien Quach CH; Paik JY; Oh H; Park JW; Lee EJ; Moon SH; Lee KH
J Nucl Med; 2013 Dec; 54(12):2161-7. PubMed ID: 24221993
[TBL] [Abstract][Full Text] [Related]
15. Canagliflozin Modulates Hypoxia-Induced Metastasis, Angiogenesis and Glycolysis by Decreasing HIF-1α Protein Synthesis via AKT/mTOR Pathway.
Luo J; Sun P; Zhang X; Lin G; Xin Q; Niu Y; Chen Y; Xu N; Zhang Y; Xie W
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948132
[TBL] [Abstract][Full Text] [Related]
16. Mitochondrial dysfunction represses HIF-1α protein synthesis through AMPK activation in human hepatoma HepG2 cells.
Hsu CC; Wang CH; Wu LC; Hsia CY; Chi CW; Yin PH; Chang CJ; Sung MT; Wei YH; Lu SH; Lee HC
Biochim Biophys Acta; 2013 Oct; 1830(10):4743-51. PubMed ID: 23791554
[TBL] [Abstract][Full Text] [Related]
17. Metabolic phenotype of bladder cancer.
Massari F; Ciccarese C; Santoni M; Iacovelli R; Mazzucchelli R; Piva F; Scarpelli M; Berardi R; Tortora G; Lopez-Beltran A; Cheng L; Montironi R
Cancer Treat Rev; 2016 Apr; 45():46-57. PubMed ID: 26975021
[TBL] [Abstract][Full Text] [Related]
18. Wogonin reverses hypoxia resistance of human colon cancer HCT116 cells via downregulation of HIF-1α and glycolysis, by inhibiting PI3K/Akt signaling pathway.
Wang H; Zhao L; Zhu LT; Wang Y; Pan D; Yao J; You QD; Guo QL
Mol Carcinog; 2014 Feb; 53 Suppl 1():E107-18. PubMed ID: 23761018
[TBL] [Abstract][Full Text] [Related]
19. Effect of orexin A on apoptosis in BGC-823 gastric cancer cells via OX1R through the AKT signaling pathway.
Wen J; Zhao Y; Shen Y; Guo L
Mol Med Rep; 2015 May; 11(5):3439-44. PubMed ID: 25586545
[TBL] [Abstract][Full Text] [Related]
20. FBP1 modulates cell metabolism of breast cancer cells by inhibiting the expression of HIF-1α.
Shi L; He C; Li Z; Wang Z; Zhang Q
Neoplasma; 2017; 64(4):535-542. PubMed ID: 28485159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
